Xcenda Global Health Economics and Outcomes Research, Palm Harbor, FL 34685, USA.
Pharmacotherapy. 2013 Apr;33(4):383-91. doi: 10.1002/phar.1223.
To determine the prevalence of postsurgical opioid use in the inpatient setting, to ascertain the frequency of and risk factors for opioid-related adverse drug events (ORADEs) among patients who received opioids, and to evaluate the impact of ORADEs on clinical and economic outcomes.
Retrospective cohort study using administrative data.
Hospital system encompassing 26 hospitals in the southeastern United States.
A total of 37,031 patients aged 18 years or older who underwent a common surgical procedure between January 1, 2009, and December 31, 2010.
Patients were evaluated for receipt of postsurgical opioids. Outcomes among opioid users included ORADE rates, hospital length of stay, total hospitalization costs, 30-day readmission rates, outlier status, and inpatient mortality. Factors associated with ORADEs were evaluated; length of stay, costs, readmissions, and mortality were compared between patients experiencing and not experiencing ORADEs by using propensity score matching on age, race-ethnicity, sex, presurgery opioid use, and comorbidities. Length of stay and cost rate ratios were generated by using negative binomial regression and generalized linear models. Odds ratios for 30-day readmissions and inpatient mortality were generated by using logistic regression. Among all surgical patients, 36,529 (98.6%) of patients received opioids, of whom 4955 (13.6%) experienced an ORADE. Increased risk of ORADEs was associated with age 65 years or older, male sex, obesity, presurgery opioid use, and higher score on Charlson Comorbidity Index. Patients with an ORADE had a 55% longer length of stay, 47% higher costs of care, 36% increased risk of 30-day readmission, and 3.4 times higher risk of inpatient mortality than did patients who did not experience an ORADE.
Opioid use was ubiquitous among hospitalized patients who underwent common surgical procedures. The observed negative outcomes of ORADEs and their impact on patients and the health care system should be considered when evaluating the balance between effectively managing postsurgical pain while minimizing the risk of ORADEs.
确定住院患者术后使用阿片类药物的流行率,确定接受阿片类药物治疗的患者中与阿片类药物相关的不良药物事件(ORADEs)的频率和风险因素,并评估 ORADEs 对临床和经济结果的影响。
使用行政数据的回顾性队列研究。
涵盖美国东南部 26 家医院的医院系统。
2009 年 1 月 1 日至 2010 年 12 月 31 日期间接受常见手术的 37031 名年龄在 18 岁或以上的患者。
评估患者是否接受术后阿片类药物治疗。阿片类药物使用者的结果包括 ORADE 发生率、住院时间、总住院费用、30 天再入院率、超高值状态和住院死亡率。评估与 ORADE 相关的因素;通过在年龄、种族-民族、性别、术前阿片类药物使用和合并症上进行倾向评分匹配,比较经历和未经历 ORADE 的患者的住院时间、成本、再入院和死亡率。使用负二项回归和广义线性模型生成住院时间和成本率比。使用逻辑回归生成 30 天再入院和住院死亡率的比值比。在所有手术患者中,36529 名(98.6%)患者接受了阿片类药物治疗,其中 4955 名(13.6%)发生了 ORADE。ORADE 风险增加与年龄 65 岁或以上、男性、肥胖、术前阿片类药物使用和 Charlson 合并症指数得分较高相关。与未发生 ORADE 的患者相比,发生 ORADE 的患者住院时间延长 55%,住院费用增加 47%,30 天再入院风险增加 36%,住院死亡率增加 3.4 倍。
在接受常见手术的住院患者中,阿片类药物的使用无处不在。在评估有效管理术后疼痛与最小化 ORADE 风险之间的平衡时,应考虑 ORADE 及其对患者和医疗保健系统的负面影响。